|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.58 CHF | +0.39% |
|
-0.54% | +1.04% |
| Jan. 20 | NOVARTIS AG : Jefferies remains Neutral | ZD |
| Jan. 17 | Sector Update: Health Care Stocks Rise Premarket Friday | MT |
| Capitalization | 197B 189B 178B 160B 281B 16,941B 314B 2,167B 803B 6,989B 737B 722B 30,590B | P/E ratio 2024 * |
17.8x | P/E ratio 2025 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise value | 211B 203B 191B 171B 302B 18,175B 337B 2,325B 862B 7,498B 791B 774B 32,819B | EV / Sales 2024 * |
4.18x | EV / Sales 2025 * | 3.99x |
| Free-Float |
87.19% | Yield 2024 * |
3.84% | Yield 2025 * | 3.96% |
More valuation ratios
* Estimated data
More news
Last Transcript: Novartis AG
More recommendations
More press releases
More news
| 1 day | -0.10% | ||
| 1 week | -1.72% | ||
| Current month | +0.60% | ||
| 1 month | +2.89% | ||
| 3 months | -11.64% | ||
| 6 months | -5.28% | ||
| Current year | +0.60% |
1 week
88.92
90.93
1 month
86.5792.08
Current year
88.1092.08
1 year
83.63102.72
3 years
72.84102.72
5 years
65.09102.72
10 years
65.09103.20
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 2018-01-31 | |
| Director of Finance/CFO | 60 | 2013-04-23 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-05-15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Sawyers
BRD | Director/Board Member | 66 | 2012-12-31 |
Bill Winters
BRD | Director/Board Member | 63 | 2012-12-31 |
| Chairman | 69 | 2012-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 10.40% | 121 M€ | -.--% | - | |
| 5.57% | 30 M€ | +1.14% | - | |
| 3.79% | 0 M€ | -25.75% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.10% | -1.72% | -4.87% | +9.63% | 197B | ||
| -4.21% | -9.00% | +15.45% | +198.49% | 653B | ||
| -0.50% | +1.77% | -9.06% | -11.03% | 354B | ||
| -4.22% | -10.08% | -24.73% | +73.23% | 341B | ||
| -1.23% | -2.93% | +4.12% | +28.96% | 303B | ||
| -2.76% | -3.03% | -17.64% | +21.26% | 248B | ||
| +0.57% | +0.76% | +9.34% | -26.90% | 236B | ||
| -1.32% | -0.26% | +2.72% | +22.08% | 206B | ||
| -0.72% | -1.87% | -7.00% | -51.34% | 149B | ||
| +0.99% | +0.71% | -11.60% | +18.88% | 146B | ||
| Average | -1.35% | -1.83% | -4.33% | +28.33% | 283.38B | |
| Weighted average by Cap. | -1.96% | -3.21% | -1.98% | +56.47% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 50.49B 48.55B 45.83B 41.05B 72.29B 4,352B 80.62B 557B 206B 1,796B 189B 185B 7,859B | 52.39B 50.38B 47.56B 42.6B 75.02B 4,517B 83.67B 578B 214B 1,863B 197B 192B 8,156B |
| Net income | 11.13B 10.7B 10.1B 9.05B 15.94B 960B 17.77B 123B 45.5B 396B 41.75B 40.89B 1,733B | 12.5B 12.02B 11.35B 10.16B 17.89B 1,077B 19.96B 138B 51.08B 444B 46.87B 45.9B 1,945B |
| Net Debt | 14.31B 13.76B 13B 11.64B 20.5B 1,234B 22.86B 158B 58.51B 509B 53.69B 52.58B 2,228B | 12.7B 12.21B 11.53B 10.33B 18.19B 1,095B 20.28B 140B 51.91B 452B 47.63B 46.65B 1,977B |
More financial data
* Estimated data
Employees
76,057
Sector
Pharmaceuticals
Calendar
2025-01-31
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-21 | 89.61 CHF | +0.43% | 91,817 |
| 25-01-20 | 89.23 CHF | -0.10% | 2,158,534 |
| 25-01-17 | 89.32 CHF | -1.40% | 3,913,141 |
| 25-01-16 | 90.59 CHF | +0.01% | 2,690,452 |
| 25-01-15 | 90.58 CHF | +0.52% | 3,004,076 |
Delayed Quote Swiss Exchange, January 20, 2025 at 11:30 am EST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
98.29USD
Average target price
112.38USD
Spread / Average Target
+14.34%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
